Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
The present invention relates to methods of diagnosing, and methods of treating, hepatocellular carcinoma in a subject. The invention also relates to polypeptide antagonists of PLVAP proteins, including humanized and chimeric antibodies that specifically bind PLVAP proteins, as well as compositions and kits comprising such polypeptide antagonists.
1. An isolated nucleic acid encoding:
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, and SEQ ID NO:102;
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:104, SEQ ID NO:106, and SEQ ID NO:108;
c) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, and SEQ ID NO:86; or
d) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:88, SEQ ID NO:90, and SEQ ID NO:92.
2. The isolated nucleic acid of claim 1 , wherein the isolated nucleic acid encodes:
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, and SEQ ID NO:102; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:104, SEQ ID NO:106, and SEQ ID NO:108.
3. The isolated nucleic acid of claim 2 , wherein the nucleic acid encodes a variable heavy domain comprising an amino acid sequence comprising SEQ ID NO: 68 or 102; and a variable light domain comprising an amino acid sequence comprising SEQ ID NO: 62 or 106.
4. The isolated nucleic acid of claim 1 , wherein the isolated nucleic acid encodes:
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, and SEQ ID NO:86; or
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:88, SEQ ID NO:90, and SEQ ID NO:92.
5. The isolated nucleic acid of claim 4 , wherein the nucleic acid encodes a variable heavy domain comprising an amino acid sequence comprising SEQ ID NO: 76 or 86; and a variable light domain comprising an amino acid sequence comprising SEQ ID NO: 72 or 92.
6. An isolated cell comprising the nucleic acid of claim 1 .
7. An isolated cell comprising the nucleic acid of claim 2 .
8. An isolated cell comprising the nucleic acid of claim 3 .
9. An isolated cell comprising the nucleic acid of claim 4 .
10. An isolated cell comprising the nucleic acid of claim 5 .
11. An isolated cell comprising:
i)
a) a first nucleic acid encoding at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, and SEQ ID NO:102; and
b) a second nucleic acid encoding at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:104, SEQ ID NO:106, and SEQ ID NO:108; or
ii)
a) a first nucleic acid encoding at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, and SEQ ID NO:86; and
b) a second nucleic acid encoding at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:88, SEQ ID NO:90, and SEQ ID NO:92.
12. An isolated protein comprising:
i)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, and SEQ ID NO:102; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:104, SEQ ID NO:106, and SEQ ID NO:108; or
ii)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, and SEQ ID NO:86; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:88, SEQ ID NO:90, and SEQ ID NO:92.
13. The protein of claim 12 , wherein the protein is bound to a radioactive isotope or a cytotoxic agent.
14. The protein of claim 12 , wherein the protein is a monoclonal antibody that specifically binds SEQ ID NO: 23.
15. A composition comprising the protein of claim 12 .
16. The composition of claim 15 , further comprising at least one chemotherapeutic agent.
17. The composition of claim 16 , wherein the chemotherapeutic agent is selected from the group consisting of doxorubicin, cisplatin, mitomycin, 5-fluorouracil, tamoxifen, sorafenib and octreotide.
18. A method of making a protein, comprising culturing the cell of claim 6 under conditions to express the protein and isolating the protein, wherein the protein comprises:
i)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, and SEQ ID NO:102; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:104, SEQ ID NO:106, and SEQ ID NO:108; or
ii)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, and SEQ ID NO:86; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:88, SEQ ID NO:90, and SEQ ID NO:92.
19. A method of making a protein, comprising culturing the cell of claim 7 under conditions to express the protein and isolating the protein, wherein the protein comprises:
i)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, and SEQ ID NO:102; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:104, SEQ ID NO:106, and SEQ ID NO:108; or
ii)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, and SEQ ID NO:86; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:88, SEQ ID NO:90, and SEQ ID NO:92.
20. A method of making a protein, comprising culturing the cell of claim 11 under conditions to express the protein and isolating the protein, wherein the protein comprises:
i)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, and SEQ ID NO:102; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:104, SEQ ID NO:106, and SEQ ID NO:108; or
ii)
a) at least one heavy chain amino acid sequence selected from the group consisting of SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, and SEQ ID NO:86; and
b) at least one kappa light chain amino acid sequence selected from the group consisting of SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:88, SEQ ID NO:90, and SEQ ID NO:92.